Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

FASEB Journal

Volumn 14, Issue 1, 2000, Pages 65-77

  Drexler, Hannes C A ^a   Risau, Werner ^a   Konerding, Moritz A ^b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Cell cycle; p27(Kip1); Proteolysis

Indexed keywords

PROTEASOME;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CATTLE; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CHICKEN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; VASCULAR ENDOTHELIUM;

ANIMALIA; BOS TAURUS; GALLUS GALLUS;

EID: 0033965742     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.1.65     Document Type: Article

References (61)

1. Thornberry, N. A., and Lazebnik, Y. (1998) Caspases - enemies within. Science 281, 1312-1316
2. Liu, X. S., Zou, H., Slaughter, C., and Wang, X. D. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184
3. Grimm, L. M., Goldberg, A. L., Poirier, G. G., Schwartz, L. M., and Osborne, B. A. (1996) Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15, 3835-3844
4. Sadoul, R., Fernandez, P.-A., Quiquerez, A.-L., Martinou, I., Maki, M., Schršter, M., Becherer, J. D., Irmler, M., Tschopp, J., and Martinou, J.-C. (1996) Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15, 3845-3852
5. Drexler, H. C. A. (1997) Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94, 855-860
6. Imajoh-Ohmi, S., Kawaguchi, T., Sugiyama, S., Tanaka, K., Omura, S., and Kikuchi, H. (1995) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217, 1070-1077
7. Fujita, E., Mukasa, T., Tsukahara, T., Arahata, K., Omura, S., and Momoi, T. (1996) Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem. Biophys. Res. Commun. 224, 74-79
8. Shinohara, K., Tomioka, M., Nakano, H., Tone, S., Ito, H., and Kawashima, S. (1996) Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317, 385-388
9. Lopes, U. G., Erhardt, P., Yao, R. J., and Cooper, G. M. (1997) P53-Dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272, 12893-12896
10. Delic, J., Masdehors, P., Omura, S., Cosset, J. M., Dumont, J., Binet, J. L., and Magdelenat, H. (1998) The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br. J. Cancer 77, 1103-1107
11. Tanimoto, Y., Onishi, Y., Hashimoto, S., and Kizaki, H. (1997) Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. 121, 542-549
12. Drexler, H. C. A. (1998) Programmed cell death and the proteasome. Apoptosis 3, 1-7
13. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease [Review]. Nature (London) 1, 27-31
14. Millauer, B., Longhi, M. P., Plate, K. H., Shawer, L. K., Risau, W., Ullrich, A., and Strawn, L. M. (1996) Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615-1620
15. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (London) 367, 576-579
16. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (London) 359, 845-848
17. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (London) 362, 841-844
18. Folkman, J. (1974) Proceedings: tumor angiogenesis factor. Cancer Res. 34, 2109-2113
19. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94, 353-362
20. Schwartz, S. M. (1978) Selection and characterization of bovine aortic endothelial cells. In Vitro 14, 966-980
21. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348, 334-336
22. Smith, P. K., Krohn, R. I., Hermanson, G. T., Malia, A. K., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using Bicinchoninic acid. Anal. Biochem. 150, 76-85
23. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 55-63
24. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279
25. Dimitropoulou, C., Malkusch, W., Fait, E., Matagoudakis, M. E., and Konerding, M. A. (1998) The vascular architecture of the chick membrane: sequential quantitative evaluation using corrosion casting. Angiogenesis 2, 255-263
26. Richardson, K. C., Jarret, L., and Finke, E. H. (1960) Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Staining Techniques 35, 313-325
27. Herren, B., Levkau, B., Raines, E. W., and Ross, R. (1998) Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis - evidence for a role for caspases and metalloproteinases. Mol. Biol. Cell 9, 1589-1601
28. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. (1993) Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985
29. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771
30. Levkau, B., Koyama, H., Raines, E. W., Clurman, B. E., Herren, B., Orth, K., Roberts, J. M., and Ross, R. (1998) Cleavage of p21(Cipl/Wafl) and p27(Kipl) mediates apoptosis in endothelial cells through activation of cdk2 - role of a caspase cascade. Mol. Cell 1, 553-563
31. Mitchell, C. A., Risau, W., and Drexler, H. C. A. (1998) Regression of vessels in the Tunica vasculosa lentis is initiated by-coordinated endothelial apoptosis - a role for vascular endothelial growth factor as a survival factor for endothelium. Dev. Dyn. 213, 322-333
32. Traenckner, E. B., Wilk, S., and Baeuerle, P. A. (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13, 5433-5441
33. Pagano, M., Tam, S. W., Theodoras, A. M., Beerromero, P., Delsal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685
34. Brown, J. P., and Pagano, M. (1997) Mechanism of P53 degradation. Biochim. Biophys. Acta 1332, O1-O6
35. Amati, B., Littlewood T. D., Evan, G. I., and Land, H. (1993) The c-myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12, 5083-5087
36. Shan, B., and Lee, W. H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173
37. He, H. L., Qi, X. M., Grossmann, J., and Distelhorst, C. W. (1998) c-Fos degradation by the proteasome - an early, Bcl-2-regulated step in apoptosis. J. Biol. Chem. 273, 25015-25019
38. Chang, Y. C., Lee, Y. S., Tejima, T., Tanaka, K., Omura, S., Heintz, N. H., Mitsui, Y., and Magae, J. (1998) Mdm2 and Bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 9, 79-84
39. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128
40. Wang, X., Gorospe, M., Huang, Y., and Holbrook, N.J. (1997) p27Kipl overexpression causes apoptotic death of mammalian cells. Oncogene 15, 2991-2997
41. Craig, C., Wersto, R., Kim, M., Ohri, E., Li, Z., Katayose, D., Lee, S. J., Trepel, J., Cowan, K., and Seth, P. (1997) A recombinant adenovirus expressing p27Kipl induces cell cycle arrest and loss of cyclin-cdk activity in human breast cancer cells. Oncogene 14, 2283-2289
42. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Florentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231-234
43. Catzavelos, C., Bhatacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Moravaprotzner, I., Kapusta, L., Franssen, E., Pritchard, K. I., and Slingerland, J. M. (1997) Decreased levels of the cell-cycle inhibitor p27(Kipl) protein - prognostic implications in primary breast cancer. Nature Med. 3, 227-230
44. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., and Roberts, J. M. (1997) Expression of cell-cycle regulators p27(Kipl) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-225
45. An, B., Goldfarb, R. H., Siman, R., and Don, Q. P. (1998) Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ. 5, 1062-1075
46. Beg, A. A., and Baltimore, D. (1996) An essential role for NF-kappa-B In preventing TNF-alpha-induced cell death. Science 274, 782-784
47. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappa-B. Science 274, 787-789
48. Wang, C. Y., Mayo, M. W., and Baldwin, A. S. (1996) TNF- and cancer therapy-induced apoptosis - potentiation by inhibition of NF-kappa-B. Science 274, 784-787
49. Chu, Z. L., McKinsey, T. A., Lin, L., Gentry, J. J., Malim, M. H., and Ballarel, D. W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-Iap2 is under NF-kappa-B control. Proc. Natl. Acad. Sci. USA 94, 10057-10062
50. Karsan, A., Yee, E., and Harlan, J. M. (1996) Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271, 27201-27204
51. Opipari, A. W., Jr., Hu, H. M., Yabkowitz, R., and Dixit, V. M. (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267, 12424-12427
52. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683
53. Cai, Z., Korner, M., Tarantino, N., and Chouaib, S. (1997) IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis. J. Biol. Chem. 272, 96-101
54. Stehlik, C., Demartin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., and Lipp, J. (1998) Nuclear factor (NF)-kappa-B-regulated X-chromosome-linked lap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188, 211-216
55. Lockyer, J. M., Colladay, J. S., Alperinlea, W. L., Hammond, T., and Buda, A. J. (1998) Inhibition of nuclear factor-kappa-B-mediated adhesion molecule expression in human endothelial cells. Circ. Res. 82, 314-320
56. Loubat, A., Rochet, N., Turchi, L., Rezzonico, R., Far, D. F., Auberger, P., Rossi, B., and Ponzio, G. (1999) Evidence for a p23 caspase-cleaved form of p27([KIP1]) involved in G(I) growth arrest. Oncogene 18, 3324-3333
57. Omura, S., Fujimolo, T., Otoguro, K., Matsuzaki, K., Moriguchi, R., Tanaka, H., and Sasaki, Y. (1991) Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J. Antibiot. (Tokyo) 44, 113-116
58. Ostrowska, H., Wojcik, C., Omura, S., and Worowski, K. (1997) Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Commun. 234, 729-732
59. Oikawa, T., Sasaki, T., Nakamura, M., Shimamura, M., Tanahashi, N., Omura, S., and Tanaka, K. (1998) The proteasome is involved in angiogenesis. Biochem. Biophys. Res. Commun. 246, 243-248
60. Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J., Destree, A., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., and Elliott, P. J. (1999) Proteasome inhibitors: A novel class of potent and effective anthumor agents. Cancer Res. 59, 2615-2622
61. Orlowski, R. Z., Eswara, J. R., Lafondwalker, A., Grever, M. R., Orlowski, M., and Dang, C. V. (1998) Tumor growth inhibition induced in a murine model of human Burkitts lymphoma by a proteasome inhibitor. Cancer Res. 58, 4342-4348